Close

Canaccord Genuity Reiterates a 'Buy' on Edwards Lifesciences (EW); TAVI Crushes It

July 25, 2012 12:45 PM EDT Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Edwards Lifesciences (NYSE: EW) price target of $123.00.

Analyst, Jason R. Mills, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login